Search for: "Sanofi US Corporation"
Results 21 - 40
of 103
Sorted by Relevance
|
Sort by Date
1 Jan 2014, 8:26 am
Genzyme is a biotechnology corporation based in Cambridge, Mass., and was acquired by Sanofi-Aventis SA in April 2011 [read post]
16 May 2012, 1:49 pm
In pleading guilty, Li, a Chinese national, admitted to stealing data on Sanofi’s compounds, including their chemical structures, and sending that data via email or through use of a thumb drive to her home computer. [read post]
9 Jun 2021, 12:51 pm
This leads us into our update today for those following the litigation against Sanofi, the producer of the popular Zantac drug mainly used for heartburn and GERDS. [read post]
7 May 2021, 12:09 pm
The Department of Justice announced this week that Incyte Corporation, a Delaware pharmaceutical company, has agreed to pay $12.6 million to resolve allegations that it violated the False Claims Act by paying kickbacks to a charitable foundation to increase prescriptions for the drug Jakafi, which is used to treat myelofibrosis, a form of leukemia that causes extensive scarring in bone marrow and leads to severe anemia and fatigue. [read post]
11 Oct 2010, 7:38 am
A lot of companies are jumping into M&A deals willingly, but that’s certainly not the case for Genzyme Corporation (GENZ), which is doing its best to fend off Sanofi-Aventis SA’s (SNY) $18.5 billion hostile takeover proposal – despite the buckets of cash that Genzyme’s executives would get in the process. [read post]
18 Feb 2011, 11:47 am
Sanofi manufactures a patented clopidogrel bisulfate drug, known as Plavix, which is used to treat patients with a risk of heart attacks and strokes. [read post]
11 May 2016, 12:39 pm
Ultimately, a French company known as Sanofi-Aventis came out with the drug Taxotere, and it was originally approved for use in the United States by the FDA in May of 1996. [read post]
21 Apr 2022, 10:07 am
Procedure: Prior art in Inter Partes Review: Baxter Corporation Englewood v. [read post]
19 Aug 2009, 5:41 am
(Patent Docs) US: BIO files amicus brief in Bilski (Patent Docs) US: Jim Greenwood on data exclusivity and healthcare innovation (BiotechBlog) (IP Watchdog) (Patent Docs) US: European biosimilars market may hint at limited US threat (GenericsWeb) US: Chris Hansen on the Myriad lawsuit (Patents4Life) Products Effexor (Venlafaxine) – US: Wyeth files suit alleging Alphapharm’s Enlafax infringes its Venlafaxine… [read post]
2 Dec 2009, 4:31 am
Because other countries just decide to pay less – Pfizer’s patent battle against UniLab (Patent Baristas) Moxifloxacin – Venezuela annuls two of Bayer’s patents relating to Moxifloxacin (IP tango) (IP tango) Plavix (Clopidogrel) – India: Indian company, Cadila, bears the brunt of section 3(d) (Spicy IP) Sanctura (Trospium) – US: Allergan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Taxotere (Docetaxel)… [read post]
20 Jun 2020, 1:57 pm
You may know it better by its drug name, Ranitidine, or from the drug company that makes it— Sanofi. [read post]
1 Jun 2009, 7:45 am
I love the idea of using flow-though shares to stimulate investment and attact expertise to Canada’s biotech and cleantech sectors. [read post]
15 Apr 2021, 10:51 am
Sanofi-Aventis U.S. [read post]
12 Sep 2019, 5:44 pm
Moreover, major drug manufacturers such as Pfizer, Shire, and Sanofi have filed antitrust suits challenging rebate walls as antitrust violations. [read post]
10 May 2019, 3:01 am
The various restrictions mean the U.S. market for the vaccine is smaller still than the already modest market Sanofi had sought. [read post]
10 May 2019, 9:24 am
The various restrictions mean the U.S. market for the vaccine is smaller still than the already modest market Sanofi had sought. [read post]
18 Nov 2014, 11:16 am
Just take a look at the Office of Inspector General’s list of “corporate integrity agreements. [read post]
22 Feb 2012, 7:37 am
Nokia Corporation v. [read post]
3 Feb 2010, 2:00 am
Barr Laboratories, Inc. and Mylan Pharma (Patent Docs) (Patently-O) Omnicef (Cefdinir) – US: CAFC on whether a product-by-process claim is infringed by an identical product made by different process: Abbott Labs v Sandoz (IP Frontline) Pertussis vaccines – UK: EWHC dismisses Medeva appeal against pertussis vaccines SPCs refusal (The SPC Blog) Plavix (Clopidogrel) – Canada: Adding some obvious flexibility: Apotex Inc v Sanofi-Synthelabo Canada Inc (IP Osgoode)… [read post]
